Pharmacy Usual Items - Australia & Oceania

  • Australia & Oceania
  • Revenue in the Pharmacy Usual Items market is projected to reach US$6.19bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.18%, resulting in a market volume of US$7.97bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$142.50 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Australia & Oceania is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Pharmacy Usual Items market in Australia & Oceania are driving the growth of the industry. Customers in this region are increasingly seeking convenience and accessibility when it comes to purchasing their usual pharmacy items. This has led to a rise in online pharmacies and the availability of pharmacy products in supermarkets and other retail outlets. Customers are also becoming more health-conscious and are seeking out natural and organic products, leading to an increase in demand for these items in the market. Trends in the market are also contributing to the growth of the Pharmacy Usual Items market in Australia & Oceania. One notable trend is the increasing focus on preventive healthcare. Customers are becoming more proactive in taking care of their health and are purchasing items such as vitamins, supplements, and health foods to support their overall well-being. Another trend is the growing demand for personalized healthcare products. Customers are looking for products that are tailored to their specific needs and preferences, such as customized skincare products or personalized vitamin packs. Local special circumstances are also playing a role in the development of the Pharmacy Usual Items market in Australia & Oceania. One such circumstance is the aging population in this region. As the population ages, there is a greater need for healthcare products and services, including pharmacy usual items. This has led to an increased demand for items such as mobility aids, home healthcare products, and medications for chronic conditions. Additionally, the high prevalence of skin cancer in Australia has resulted in a greater demand for sun protection products, contributing to the growth of the market. Underlying macroeconomic factors are also driving the growth of the Pharmacy Usual Items market in Australia & Oceania. The region has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. This has allowed customers to allocate more of their budget towards healthcare and wellness products, including pharmacy usual items. Additionally, the region's strong healthcare infrastructure and government support for the pharmaceutical industry have created a favorable business environment for companies operating in this market. In conclusion, the Pharmacy Usual Items market in Australia & Oceania is experiencing growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customers in this region are seeking convenience, accessibility, and personalized healthcare products, driving the demand for pharmacy usual items. The aging population, high prevalence of skin cancer, and strong healthcare infrastructure further contribute to the growth of the market. Overall, the future looks promising for the Pharmacy Usual Items market in Australia & Oceania.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)